Mdx.V
MDX.V operates in the Advanced Medical Equipment & Technology industry, providing specialized medical equipment and technology solutions to healthcare providers and institutions.
Business. MDX.V operates in the Advanced Medical Equipment & Technology industry, providing specialized medical equipment and technology solutions to healthcare providers and institutions.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
MDX.V operates in the Advanced Medical Equipment & Technology industry, providing specialized medical equipment and technology solutions to healthcare providers and institutions.
MDX.V's capital structure is highly leveraged, with total liabilities of CAD 940.8 million and total equity of CAD -852.4 million, resulting in a negative debt-to-equity ratio of -0.82. The company's liquidity position is weak, as evidenced by a current ratio of 0.1, indicating that it has insufficient current assets to cover its current liabilities. Free cash flow is negative at CAD -3.6 million, and operating cash flow is also negative at CAD -2.5 million, suggesting that the company is not generating sufficient cash from operations to sustain its activities.
Profitability metrics for MDX.V are mixed. The company reports a gross profit of CAD 194.2 million, but this is offset by a net loss of CAD -36.5 million, resulting in a negative return on assets of -4.13%. The return on equity is positive at 42.85%, but this is misleading due to the negative equity base, which inflates the ratio. These figures suggest that the company is not currently generating sustainable profits and may be struggling to cover its operating costs.
MDX.V's revenue is concentrated in a single business segment, as no segment breakdown is provided in the available data. The company's geographic exposure is not specified, but the financial data is reported in Canadian dollars, indicating that the company is likely headquartered in Canada. The lack of segment and geographic detail limits the ability to assess diversification risks.
The company's growth trajectory is uncertain. No specific growth metrics or outlooks are provided in the available data, and the negative net income and operating cash flow suggest that the company is not currently expanding its operations. The absence of capital expenditures further indicates that the company is not investing in new projects or infrastructure.
Risk factors for MDX.V include a weak liquidity position and a high debt burden. The company has a negative net cash position after subtracting total debt, which increases the risk of insolvency. The risk assessment indicates a medium liquidity risk and a low dilution risk, suggesting that while the company may face challenges in meeting short-term obligations, it is not currently at high risk of issuing additional shares to raise capital. The negative equity and high debt levels also suggest that the company may be vulnerable to economic downturns or changes in interest rates.
Recent events and disclosures for MDX.V are limited in the available data. No specific filings or transcripts are provided, but the company's financial performance and capital structure suggest that it may be facing operational and financial challenges. The lack of analyst recommendations and the uniform price target of CAD 0.28 indicate that there is limited investor confidence in the company's future performance.
- MDX.V has a highly leveraged capital structure with a negative equity position and a debt-to-equity ratio of -0.82.
- The company is not generating positive net income and has a negative operating cash flow, indicating financial distress.
- There is no segment or geographic diversification data available, limiting the ability to assess business risk.
- Analysts have issued a single "buy" recommendation with a uniform price target of CAD 0.28, suggesting limited investor confidence.
- The company's liquidity position is weak, with a current ratio of 0.1 and no capital expenditures reported.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,02 |
| Revenue | —no estimate | —no estimate | 3,5M CAD |
| Operating income | —no estimate | —no estimate | -3,6M CAD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- MDX.V Market data — financials · 2026-05-28
- Medx Health Corp Market data — analyst estimates · 2026-05-28